COGT
Cogent Biosciences Inc
32.60$
+2.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.1% | 92.3% | 86.3% | 94.3% | 82.1% | 97.6% | 95.9% | 88.1% | 86.4% | 90.4% | 97.1% | |
| 95.5% | 54.7% | 57.6% | 64.8% | 75.7% | 96.5% | 94.7% | 46.5% | 17.0% | 29.9% | 33.3% | |
| 95.5% | 90.7% | 83.4% | 91.5% | 75.7% | 96.5% | 94.7% | 86.2% | 84.8% | 87.6% | 96.1% | |
| 0.3% | 1.2% | 1.7% | 1.9% | 4.0% | 0.0% | – | – | – | – | – | |
| – | – | 0.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | 14.5% | 1.9% | 0.7% | 2.6% | – | – | – | |
| 26.6% | 30.7% | 42.4% | 29.9% | 35.7% | 6.5% | 7.7% | 15.0% | 17.7% | 21.8% | 32.1% | |
| 7.7% | 11.6% | 22.8% | 29.0% | 26.8% | 5.2% | 7.4% | 8.9% | 12.2% | 17.0% | 6.8% | |
| 0.0% | 1.6% | 5.6% | 4.4% | 3.3% | 0.8% | 1.0% | 0.5% | 0.4% | 0.5% | 0.2% | |
| 1.5% | 1.9% | 2.7% | 1.8% | 6.4% | 0.3% | 1.5% | 1.9% | 3.4% | 3.7% | 1.0% | |
| – | – | – | – | – | – | – | – | – | – | 23.8% | |
| 73.4% | 69.3% | 57.6% | 70.1% | 64.3% | 93.5% | 92.3% | 85.0% | 82.3% | 78.2% | 67.9% | |
| -8.1% | -34.2% | -104.5% | -107.1% | -250.7% | -79.2% | -116.8% | -136.7% | -192.6% | -262.1% | -126.8% | |
| 7.8% | 9.8% | 15.1% | 7.2% | 15.4% | 4.4% | 16.7% | 19.5% | 25.4% | 33.7% | 17.2% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.